Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study

Autor:	Masako Ito, Seitaro Yoshida, Masato Tobinai, Junko Hashimoto, Toshitaka Nakamura
Rok vydání:	2015
Předmět:	Fracture risk Male medicine.medical_specialty Endocrinology Diabetes and Metabolism Urology 030209 endocrinology & metabolism 03 medical and health sciences 0302 clinical medicine Endocrinology Asian People Japan Bone Density medicine Humans Orthopedics and Sports Medicine In patient Ibandronic Acid Femoral neck Aged 030203 arthritis & rheumatology Bone mineral Aged 80 and over Diphosphonates business.industry Femur Neck Incidence (epidemiology) General Medicine Middle Aged Spine Surgery Femoral Neck Fractures medicine.anatomical_structure Risk osteoporosis Osteoporosis Spinal Fractures Female business Risedronic Acid Fracture reduction
Zdroj:	Journal of bone and mineral metabolism. 35(1)
ISSN:	1435-5604
Popis:	We examined the efficacy of intravenous (IV) ibandronate 1 mg/month in patient subgroups in the phase III MOVER study. Here we present results of analyses on the incidence of fractures in patients with prevalent vertebral fractures (1 or ≥2, and ≥3) at screening and femoral neck (FN) bone mineral density (BMD) T scores ≥−2.5 or
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29beb4c2826652952cb7a390fa4feafc https://pubmed.ncbi.nlm.nih.gov/26614597 Zobrazit plný text záznamu Full text from SpringerLink